Category: ETFs |
Launch Date: 05-07-2021 |
Asset Class: |
Benchmark: NIFTY Pharma TRI |
TER: 0.21% As on (31-08-2025) |
Status: Open Ended Schemes |
Minimum Investment: 1000.0 |
Minimum Topup: 0.0 |
Total Assets: 993.86 Cr As on 29-08-2025(Source:AMFI) |
Turn over: 45% | Exit Load: Not Applicable |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Standard Deviation | |
Sharpe Ratio | |
Alpha | |
Beta | |
Yield to Maturity | - |
Average Maturity | - |
Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
---|---|---|---|---|---|---|
Nippon India Nifty Pharma ETF | 05-07-2021 | -7.39 | 18.4 | 18.83 | - | - |
Aditya Birla Sun Life Silver ETF | 28-01-2022 | 56.39 | 39.23 | 34.72 | - | - |
ICICI Prudential Silver ETF | 21-01-2022 | 56.37 | 39.2 | 34.79 | - | - |
Axis Silver ETF | 05-09-2022 | 56.26 | 39.63 | 34.77 | - | - |
Mirae Asset Silver ETF | 09-06-2023 | 56.21 | 39.04 | - | - | - |
Kotak Silver ETF | 05-12-2022 | 56.18 | 39.17 | - | - | - |
DSP Silver ETF | 19-08-2022 | 56.17 | 39.0 | 34.4 | - | - |
HDFC Silver ETF - Growth Option | 05-09-2022 | 56.09 | 39.6 | 34.62 | - | - |
SBI Silver ETF | 05-07-2024 | 56.03 | - | - | - | - |
Nippon India Silver ETF | 05-02-2022 | 55.89 | 38.85 | 34.43 | - | - |
Minimum investment in securities of a particular index (which is being replicated/ tracked) - 95% of total assets.
Small Cap
5.58%
Others
0.03%
Large Cap
70.49%
Mid Cap
23.9%